Amlodipine as add-on to Olmesartan in Hypertension

NCT00220220 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

429

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: olmesartan medoxomil
DRUG: amlodipine

Sponsor

Sankyo Pharma Gmbh